Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for DBVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
March 31, 2026 266.40M
December 31, 2025 233.72M
September 30, 2025 110.50M
June 30, 2025 143.43M
March 31, 2025 50.56M
December 31, 2024 65.66M
September 30, 2024 93.06M
June 30, 2024 114.19M
March 31, 2024 145.90M
December 31, 2023 182.99M
September 30, 2023 189.78M
Date Value
June 30, 2023 217.52M
March 31, 2023 232.93M
December 31, 2022 246.52M
September 30, 2022 248.12M
June 30, 2022 284.98M
March 31, 2022 117.58M
December 31, 2021 146.32M
September 30, 2021 170.92M
June 30, 2021 200.58M
March 31, 2021 221.40M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Cellectis SA 267.36M
Akari Therapeutics Plc 38.62M
EDAP TMS SA 74.55M
Autolus Therapeutics Plc 493.23M
Evaxion AS 19.38M

Total Assets (Quarterly) Related Metrics